Global Prothrombin Complex Concentrate (PCC) Drug Market Research Report 2026(Status and Outlook)
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Prothrombin Complex Concentrate (PCC) Drug competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Prothrombin Complex Concentrate (PCC) drugs are plasma-derived, multi-factor coagulation products purified and viral-inactivated from human plasma. They primarily contain four vitamin K-dependent clotting factors?II, VII, IX, and X?and may also include natural anticoagulants such as protein C and protein S. PCC drugs are indicated for the treatment or prevention of bleeding caused by deficiencies in these factors, particularly in cases of warfarin overdose, severe liver dysfunction, or congenital coagulation disorders. Compared with traditional fresh frozen plasma, PCC offers faster onset of action, lower infusion volumes, and reduced infection risks, making it widely used in emergency anticoagulation reversal, surgical hemostasis, and critical bleeding management. With the growing number of patients on anticoagulant therapy and rising surgical and trauma care needs, PCC drugs are emerging as one of the fastest-growing segments in the global plasma-derived therapeutics market.In 2024, global Prothrombin Complex Concentrate (PCC) drugs production reached approximately 4.73 m units, with an average global market price of around US$ 280 perunit.The average gross profit margin of this product is 80%.The expansion of the PCC drug market is driven by the growing clinical demand and the increasing reliance of healthcare systems on rapid hemostatic solutions. The rising prevalence of patients on anticoagulant therapy?especially those with atrial fibrillation, deep vein thrombosis, or valvular heart disease?has created significant demand for effective reversal agents. Furthermore, PCC?s rapid hemostatic effect in high-risk surgical procedures such as trauma, neurosurgery, and cardiothoracic operations has established it as a critical emergency medicine. New-generation four-factor PCCs are now recommended over three-factor formulations due to their superior efficacy in reversing warfarin effects. Meanwhile, technological advancements in viral inactivation, nanofiltration, and lyophilization have markedly enhanced product safety and stability, boosting market adoption worldwide.Despite strong growth prospects, the PCC drug industry faces several structural challenges. The supply of human plasma remains constrained and highly regulated, with geographical concentration creating vulnerability to supply chain disruptions. Additionally, the risk of thrombosis associated with high-dose or repeated PCC administration imposes clinical caution. The long production cycle, complex cost structure, and high technical barriers also create significant entry challenges for new manufacturers. In some regions, the preference for lower-cost alternatives such as fresh frozen plasma or recombinant coagulation factors slows PCC adoption. Moreover, variations in national regulatory frameworks and blood product standards may further complicate global market expansion and compliance efforts.The downstream demand for PCC drugs is becoming increasingly diversified. While traditionally used for warfarin reversal and management of severe bleeding, recent years have seen expanded indications, including bleeding associated with direct oral anticoagulants (DOACs), liver disease-related coagulopathy, perioperative anticoagulant reversal, and obstetric hemorrhage. National clinical guidelines have progressively positioned PCC as a first-line therapy for anticoagulation reversal, accelerating its adoption. In developed markets, PCC use has extended from intensive care units to emergency and general wards. In emerging economies, government healthcare programs and local plasma fractionation initiatives are driving broader market penetration. Looking ahead, standardized hospital inventory practices, emergency medicine training, and combined therapeutic protocols involving PCC and other hemostatic agents will further broaden its clinical scope.The production of PCC drugs relies heavily on human plasma as the primary biological raw material. Its quality, supply stability, and regulatory compliance directly determine production capacity and product safety standards. Most plasma collection currently occurs in North America and Europe, where mature donor networks and traceable oversight systems are in place. With gradual policy liberalization, Asian countries such as China and India are emerging as new sources of plasma supply growth. In addition to plasma, the upstream chain involves critical components such as viral inactivation reagents, chromatographic media, and lyophilization equipment. While technological advances have improved yield and purity, the stringent ethical and regulatory constraints on plasma sourcing and international transport remain key bottlenecks in the global PCC supply chain.
The global Prothrombin Complex Concentrate (PCC) Drug market size was estimated at USD 1324.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Prothrombin Complex Concentrate (PCC) Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Prothrombin Complex Concentrate (PCC) Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Prothrombin Complex Concentrate (PCC) Drug market.
Global Prothrombin Complex Concentrate (PCC) Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
RAAS
Hualan Bio
BOHUI
NUOYI BIO
SINOPHARM
Guangdong Weilun
Weiguang Bio
Kangbo Bio
Huarun Boya
Taibang Biologic
Market Segmentation (by Type)
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other
Market Segmentation (by Application)
Hemophilia B
Acquired Coagulation Factor Deficiency
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Prothrombin Complex Concentrate (PCC) Drug Market
Overview of the regional outlook of the Prothrombin Complex Concentrate (PCC) Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Prothrombin Complex Concentrate (PCC) Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Prothrombin Complex Concentrate (PCC) Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Prothrombin Complex Concentrate (PCC) Drug market size was estimated at USD 1324.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Prothrombin Complex Concentrate (PCC) Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Prothrombin Complex Concentrate (PCC) Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Prothrombin Complex Concentrate (PCC) Drug market.
Global Prothrombin Complex Concentrate (PCC) Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
RAAS
Hualan Bio
BOHUI
NUOYI BIO
SINOPHARM
Guangdong Weilun
Weiguang Bio
Kangbo Bio
Huarun Boya
Taibang Biologic
Market Segmentation (by Type)
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other
Market Segmentation (by Application)
Hemophilia B
Acquired Coagulation Factor Deficiency
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Prothrombin Complex Concentrate (PCC) Drug Market
Overview of the regional outlook of the Prothrombin Complex Concentrate (PCC) Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Prothrombin Complex Concentrate (PCC) Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Prothrombin Complex Concentrate (PCC) Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Prothrombin Complex Concentrate (PCC) Drug
1.2 Key Market Segments
1.2.1 Prothrombin Complex Concentrate (PCC) Drug Segment by Type
1.2.2 Prothrombin Complex Concentrate (PCC) Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Prothrombin Complex Concentrate (PCC) Drug Product Life Cycle
3.3 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Manufacturers (2020-2025)
3.4 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Prothrombin Complex Concentrate (PCC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Prothrombin Complex Concentrate (PCC) Drug Market Competitive Situation and Trends
3.8.1 Prothrombin Complex Concentrate (PCC) Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Prothrombin Complex Concentrate (PCC) Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG INDUSTRY CHAIN ANALYSIS
4.1 Prothrombin Complex Concentrate (PCC) Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Prothrombin Complex Concentrate (PCC) Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Prothrombin Complex Concentrate (PCC) Drug Market
5.7 ESG Ratings of Leading Companies
6 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2020-2025)
6.3 Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Type (2020-2025)
6.4 Global Prothrombin Complex Concentrate (PCC) Drug Price by Type (2020-2025)
7 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Sales by Application (2020-2025)
7.3 Global Prothrombin Complex Concentrate (PCC) Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Prothrombin Complex Concentrate (PCC) Drug Sales Growth Rate by Application (2020-2025)
8 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET SALES BY REGION
8.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region
8.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region
8.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region
8.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region
8.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region
8.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region
8.3 North America
8.3.1 North America Prothrombin Complex Concentrate (PCC) Drug Sales by Country
8.3.2 North America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country
8.4.2 Europe Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales by Region
8.5.2 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Prothrombin Complex Concentrate (PCC) Drug Sales by Country
8.6.2 South America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Region
8.7.2 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Prothrombin Complex Concentrate (PCC) Drug by Region(2020-2025)
9.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Region (2020-2025)
9.3 Global Prothrombin Complex Concentrate (PCC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Prothrombin Complex Concentrate (PCC) Drug Production
9.4.1 North America Prothrombin Complex Concentrate (PCC) Drug Production Growth Rate (2020-2025)
9.4.2 North America Prothrombin Complex Concentrate (PCC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Prothrombin Complex Concentrate (PCC) Drug Production
9.5.1 Europe Prothrombin Complex Concentrate (PCC) Drug Production Growth Rate (2020-2025)
9.5.2 Europe Prothrombin Complex Concentrate (PCC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Prothrombin Complex Concentrate (PCC) Drug Production (2020-2025)
9.6.1 Japan Prothrombin Complex Concentrate (PCC) Drug Production Growth Rate (2020-2025)
9.6.2 Japan Prothrombin Complex Concentrate (PCC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Prothrombin Complex Concentrate (PCC) Drug Production (2020-2025)
9.7.1 China Prothrombin Complex Concentrate (PCC) Drug Production Growth Rate (2020-2025)
9.7.2 China Prothrombin Complex Concentrate (PCC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CSL Behring
10.1.1 CSL Behring Basic Information
10.1.2 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.1.3 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.1.4 CSL Behring Business Overview
10.1.5 CSL Behring SWOT Analysis
10.1.6 CSL Behring Recent Developments
10.2 Grifols
10.2.1 Grifols Basic Information
10.2.2 Grifols Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.2.3 Grifols Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.2.4 Grifols Business Overview
10.2.5 Grifols SWOT Analysis
10.2.6 Grifols Recent Developments
10.3 Octapharma
10.3.1 Octapharma Basic Information
10.3.2 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.3.3 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.3.4 Octapharma Business Overview
10.3.5 Octapharma SWOT Analysis
10.3.6 Octapharma Recent Developments
10.4 Prothya Biosolutions
10.4.1 Prothya Biosolutions Basic Information
10.4.2 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.4.3 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.4.4 Prothya Biosolutions Business Overview
10.4.5 Prothya Biosolutions Recent Developments
10.5 Takeda
10.5.1 Takeda Basic Information
10.5.2 Takeda Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.5.3 Takeda Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.5.4 Takeda Business Overview
10.5.5 Takeda Recent Developments
10.6 RAAS
10.6.1 RAAS Basic Information
10.6.2 RAAS Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.6.3 RAAS Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.6.4 RAAS Business Overview
10.6.5 RAAS Recent Developments
10.7 Hualan Bio
10.7.1 Hualan Bio Basic Information
10.7.2 Hualan Bio Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.7.3 Hualan Bio Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.7.4 Hualan Bio Business Overview
10.7.5 Hualan Bio Recent Developments
10.8 BOHUI
10.8.1 BOHUI Basic Information
10.8.2 BOHUI Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.8.3 BOHUI Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.8.4 BOHUI Business Overview
10.8.5 BOHUI Recent Developments
10.9 NUOYI BIO
10.9.1 NUOYI BIO Basic Information
10.9.2 NUOYI BIO Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.9.3 NUOYI BIO Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.9.4 NUOYI BIO Business Overview
10.9.5 NUOYI BIO Recent Developments
10.10 SINOPHARM
10.10.1 SINOPHARM Basic Information
10.10.2 SINOPHARM Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.10.3 SINOPHARM Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.10.4 SINOPHARM Business Overview
10.10.5 SINOPHARM Recent Developments
10.11 Guangdong Weilun
10.11.1 Guangdong Weilun Basic Information
10.11.2 Guangdong Weilun Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.11.3 Guangdong Weilun Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.11.4 Guangdong Weilun Business Overview
10.11.5 Guangdong Weilun Recent Developments
10.12 Weiguang Bio
10.12.1 Weiguang Bio Basic Information
10.12.2 Weiguang Bio Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.12.3 Weiguang Bio Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.12.4 Weiguang Bio Business Overview
10.12.5 Weiguang Bio Recent Developments
10.13 Kangbo Bio
10.13.1 Kangbo Bio Basic Information
10.13.2 Kangbo Bio Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.13.3 Kangbo Bio Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.13.4 Kangbo Bio Business Overview
10.13.5 Kangbo Bio Recent Developments
10.14 Huarun Boya
10.14.1 Huarun Boya Basic Information
10.14.2 Huarun Boya Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.14.3 Huarun Boya Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.14.4 Huarun Boya Business Overview
10.14.5 Huarun Boya Recent Developments
10.15 Taibang Biologic
10.15.1 Taibang Biologic Basic Information
10.15.2 Taibang Biologic Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.15.3 Taibang Biologic Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.15.4 Taibang Biologic Business Overview
10.15.5 Taibang Biologic Recent Developments
11 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET FORECAST BY REGION
11.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast
11.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Country
11.2.3 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Region
11.2.4 South America Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Prothrombin Complex Concentrate (PCC) Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Prothrombin Complex Concentrate (PCC) Drug by Type (2026-2035)
12.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Prothrombin Complex Concentrate (PCC) Drug by Type (2026-2035)
12.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Forecast by Application (2026-2035)
12.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales (K MT) Forecast by Application
12.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Prothrombin Complex Concentrate (PCC) Drug
1.2 Key Market Segments
1.2.1 Prothrombin Complex Concentrate (PCC) Drug Segment by Type
1.2.2 Prothrombin Complex Concentrate (PCC) Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Prothrombin Complex Concentrate (PCC) Drug Product Life Cycle
3.3 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Manufacturers (2020-2025)
3.4 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Prothrombin Complex Concentrate (PCC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Prothrombin Complex Concentrate (PCC) Drug Market Competitive Situation and Trends
3.8.1 Prothrombin Complex Concentrate (PCC) Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Prothrombin Complex Concentrate (PCC) Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG INDUSTRY CHAIN ANALYSIS
4.1 Prothrombin Complex Concentrate (PCC) Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Prothrombin Complex Concentrate (PCC) Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Prothrombin Complex Concentrate (PCC) Drug Market
5.7 ESG Ratings of Leading Companies
6 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2020-2025)
6.3 Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Type (2020-2025)
6.4 Global Prothrombin Complex Concentrate (PCC) Drug Price by Type (2020-2025)
7 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Sales by Application (2020-2025)
7.3 Global Prothrombin Complex Concentrate (PCC) Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Prothrombin Complex Concentrate (PCC) Drug Sales Growth Rate by Application (2020-2025)
8 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET SALES BY REGION
8.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region
8.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region
8.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region
8.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region
8.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region
8.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region
8.3 North America
8.3.1 North America Prothrombin Complex Concentrate (PCC) Drug Sales by Country
8.3.2 North America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country
8.4.2 Europe Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales by Region
8.5.2 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Prothrombin Complex Concentrate (PCC) Drug Sales by Country
8.6.2 South America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Region
8.7.2 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Prothrombin Complex Concentrate (PCC) Drug by Region(2020-2025)
9.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Region (2020-2025)
9.3 Global Prothrombin Complex Concentrate (PCC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Prothrombin Complex Concentrate (PCC) Drug Production
9.4.1 North America Prothrombin Complex Concentrate (PCC) Drug Production Growth Rate (2020-2025)
9.4.2 North America Prothrombin Complex Concentrate (PCC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Prothrombin Complex Concentrate (PCC) Drug Production
9.5.1 Europe Prothrombin Complex Concentrate (PCC) Drug Production Growth Rate (2020-2025)
9.5.2 Europe Prothrombin Complex Concentrate (PCC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Prothrombin Complex Concentrate (PCC) Drug Production (2020-2025)
9.6.1 Japan Prothrombin Complex Concentrate (PCC) Drug Production Growth Rate (2020-2025)
9.6.2 Japan Prothrombin Complex Concentrate (PCC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Prothrombin Complex Concentrate (PCC) Drug Production (2020-2025)
9.7.1 China Prothrombin Complex Concentrate (PCC) Drug Production Growth Rate (2020-2025)
9.7.2 China Prothrombin Complex Concentrate (PCC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CSL Behring
10.1.1 CSL Behring Basic Information
10.1.2 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.1.3 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.1.4 CSL Behring Business Overview
10.1.5 CSL Behring SWOT Analysis
10.1.6 CSL Behring Recent Developments
10.2 Grifols
10.2.1 Grifols Basic Information
10.2.2 Grifols Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.2.3 Grifols Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.2.4 Grifols Business Overview
10.2.5 Grifols SWOT Analysis
10.2.6 Grifols Recent Developments
10.3 Octapharma
10.3.1 Octapharma Basic Information
10.3.2 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.3.3 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.3.4 Octapharma Business Overview
10.3.5 Octapharma SWOT Analysis
10.3.6 Octapharma Recent Developments
10.4 Prothya Biosolutions
10.4.1 Prothya Biosolutions Basic Information
10.4.2 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.4.3 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.4.4 Prothya Biosolutions Business Overview
10.4.5 Prothya Biosolutions Recent Developments
10.5 Takeda
10.5.1 Takeda Basic Information
10.5.2 Takeda Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.5.3 Takeda Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.5.4 Takeda Business Overview
10.5.5 Takeda Recent Developments
10.6 RAAS
10.6.1 RAAS Basic Information
10.6.2 RAAS Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.6.3 RAAS Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.6.4 RAAS Business Overview
10.6.5 RAAS Recent Developments
10.7 Hualan Bio
10.7.1 Hualan Bio Basic Information
10.7.2 Hualan Bio Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.7.3 Hualan Bio Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.7.4 Hualan Bio Business Overview
10.7.5 Hualan Bio Recent Developments
10.8 BOHUI
10.8.1 BOHUI Basic Information
10.8.2 BOHUI Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.8.3 BOHUI Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.8.4 BOHUI Business Overview
10.8.5 BOHUI Recent Developments
10.9 NUOYI BIO
10.9.1 NUOYI BIO Basic Information
10.9.2 NUOYI BIO Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.9.3 NUOYI BIO Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.9.4 NUOYI BIO Business Overview
10.9.5 NUOYI BIO Recent Developments
10.10 SINOPHARM
10.10.1 SINOPHARM Basic Information
10.10.2 SINOPHARM Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.10.3 SINOPHARM Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.10.4 SINOPHARM Business Overview
10.10.5 SINOPHARM Recent Developments
10.11 Guangdong Weilun
10.11.1 Guangdong Weilun Basic Information
10.11.2 Guangdong Weilun Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.11.3 Guangdong Weilun Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.11.4 Guangdong Weilun Business Overview
10.11.5 Guangdong Weilun Recent Developments
10.12 Weiguang Bio
10.12.1 Weiguang Bio Basic Information
10.12.2 Weiguang Bio Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.12.3 Weiguang Bio Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.12.4 Weiguang Bio Business Overview
10.12.5 Weiguang Bio Recent Developments
10.13 Kangbo Bio
10.13.1 Kangbo Bio Basic Information
10.13.2 Kangbo Bio Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.13.3 Kangbo Bio Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.13.4 Kangbo Bio Business Overview
10.13.5 Kangbo Bio Recent Developments
10.14 Huarun Boya
10.14.1 Huarun Boya Basic Information
10.14.2 Huarun Boya Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.14.3 Huarun Boya Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.14.4 Huarun Boya Business Overview
10.14.5 Huarun Boya Recent Developments
10.15 Taibang Biologic
10.15.1 Taibang Biologic Basic Information
10.15.2 Taibang Biologic Prothrombin Complex Concentrate (PCC) Drug Product Overview
10.15.3 Taibang Biologic Prothrombin Complex Concentrate (PCC) Drug Product Market Performance
10.15.4 Taibang Biologic Business Overview
10.15.5 Taibang Biologic Recent Developments
11 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET FORECAST BY REGION
11.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast
11.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Country
11.2.3 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Region
11.2.4 South America Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Prothrombin Complex Concentrate (PCC) Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Prothrombin Complex Concentrate (PCC) Drug by Type (2026-2035)
12.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Prothrombin Complex Concentrate (PCC) Drug by Type (2026-2035)
12.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Forecast by Application (2026-2035)
12.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales (K MT) Forecast by Application
12.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Type (M USD)
Table 4. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Application
Table 5. Prothrombin Complex Concentrate (PCC) Drug Market Size Comparison by Region (M USD)
Table 6. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prothrombin Complex Concentrate (PCC) Drug as of 2025)
Table 11. Global Market Prothrombin Complex Concentrate (PCC) Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Prothrombin Complex Concentrate (PCC) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Prothrombin Complex Concentrate (PCC) Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (K MT)
Table 27. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Type (M USD)
Table 28. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2020-2025)
Table 30. Global Prothrombin Complex Concentrate (PCC) Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Type (2020-2025)
Table 32. Global Prothrombin Complex Concentrate (PCC) Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K MT) by Application
Table 34. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Application
Table 35. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2020-2025)
Table 37. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Application (2020-2025)
Table 39. Global Prothrombin Complex Concentrate (PCC) Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2020-2025)
Table 42. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region (2020-2025)
Table 44. North America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Prothrombin Complex Concentrate (PCC) Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Prothrombin Complex Concentrate (PCC) Drug Production (K MT) by Region(2020-2025)
Table 55. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Prothrombin Complex Concentrate (PCC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Prothrombin Complex Concentrate (PCC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Prothrombin Complex Concentrate (PCC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Prothrombin Complex Concentrate (PCC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Prothrombin Complex Concentrate (PCC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. CSL Behring Basic Information
Table 63. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 64. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. CSL Behring Business Overview
Table 66. CSL Behring SWOT Analysis
Table 67. CSL Behring Recent Developments
Table 68. Grifols Basic Information
Table 69. Grifols Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 70. Grifols Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Grifols Business Overview
Table 72. Grifols SWOT Analysis
Table 73. Grifols Recent Developments
Table 74. Octapharma Basic Information
Table 75. Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 76. Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Octapharma Business Overview
Table 78. Octapharma SWOT Analysis
Table 79. Octapharma Recent Developments
Table 80. Prothya Biosolutions Basic Information
Table 81. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 82. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Prothya Biosolutions Business Overview
Table 84. Prothya Biosolutions Recent Developments
Table 85. Takeda Basic Information
Table 86. Takeda Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 87. Takeda Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Takeda Business Overview
Table 89. Takeda Recent Developments
Table 90. RAAS Basic Information
Table 91. RAAS Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 92. RAAS Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. RAAS Business Overview
Table 94. RAAS Recent Developments
Table 95. Hualan Bio Basic Information
Table 96. Hualan Bio Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 97. Hualan Bio Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Hualan Bio Business Overview
Table 99. Hualan Bio Recent Developments
Table 100. BOHUI Basic Information
Table 101. BOHUI Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 102. BOHUI Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. BOHUI Business Overview
Table 104. BOHUI Recent Developments
Table 105. NUOYI BIO Basic Information
Table 106. NUOYI BIO Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 107. NUOYI BIO Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. NUOYI BIO Business Overview
Table 109. NUOYI BIO Recent Developments
Table 110. SINOPHARM Basic Information
Table 111. SINOPHARM Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 112. SINOPHARM Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. SINOPHARM Business Overview
Table 114. SINOPHARM Recent Developments
Table 115. Guangdong Weilun Basic Information
Table 116. Guangdong Weilun Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 117. Guangdong Weilun Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Guangdong Weilun Business Overview
Table 119. Guangdong Weilun Recent Developments
Table 120. Weiguang Bio Basic Information
Table 121. Weiguang Bio Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 122. Weiguang Bio Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Weiguang Bio Business Overview
Table 124. Weiguang Bio Recent Developments
Table 125. Kangbo Bio Basic Information
Table 126. Kangbo Bio Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 127. Kangbo Bio Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Kangbo Bio Business Overview
Table 129. Kangbo Bio Recent Developments
Table 130. Huarun Boya Basic Information
Table 131. Huarun Boya Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 132. Huarun Boya Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Huarun Boya Business Overview
Table 134. Huarun Boya Recent Developments
Table 135. Taibang Biologic Basic Information
Table 136. Taibang Biologic Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 137. Taibang Biologic Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Taibang Biologic Business Overview
Table 139. Taibang Biologic Recent Developments
Table 140. Global Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Prothrombin Complex Concentrate (PCC) Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Type (M USD)
Table 4. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Application
Table 5. Prothrombin Complex Concentrate (PCC) Drug Market Size Comparison by Region (M USD)
Table 6. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prothrombin Complex Concentrate (PCC) Drug as of 2025)
Table 11. Global Market Prothrombin Complex Concentrate (PCC) Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Prothrombin Complex Concentrate (PCC) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Prothrombin Complex Concentrate (PCC) Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (K MT)
Table 27. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Type (M USD)
Table 28. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2020-2025)
Table 30. Global Prothrombin Complex Concentrate (PCC) Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Type (2020-2025)
Table 32. Global Prothrombin Complex Concentrate (PCC) Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K MT) by Application
Table 34. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Application
Table 35. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2020-2025)
Table 37. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Application (2020-2025)
Table 39. Global Prothrombin Complex Concentrate (PCC) Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2020-2025)
Table 42. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region (2020-2025)
Table 44. North America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Prothrombin Complex Concentrate (PCC) Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Prothrombin Complex Concentrate (PCC) Drug Production (K MT) by Region(2020-2025)
Table 55. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Prothrombin Complex Concentrate (PCC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Prothrombin Complex Concentrate (PCC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Prothrombin Complex Concentrate (PCC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Prothrombin Complex Concentrate (PCC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Prothrombin Complex Concentrate (PCC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. CSL Behring Basic Information
Table 63. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 64. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. CSL Behring Business Overview
Table 66. CSL Behring SWOT Analysis
Table 67. CSL Behring Recent Developments
Table 68. Grifols Basic Information
Table 69. Grifols Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 70. Grifols Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Grifols Business Overview
Table 72. Grifols SWOT Analysis
Table 73. Grifols Recent Developments
Table 74. Octapharma Basic Information
Table 75. Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 76. Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Octapharma Business Overview
Table 78. Octapharma SWOT Analysis
Table 79. Octapharma Recent Developments
Table 80. Prothya Biosolutions Basic Information
Table 81. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 82. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Prothya Biosolutions Business Overview
Table 84. Prothya Biosolutions Recent Developments
Table 85. Takeda Basic Information
Table 86. Takeda Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 87. Takeda Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Takeda Business Overview
Table 89. Takeda Recent Developments
Table 90. RAAS Basic Information
Table 91. RAAS Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 92. RAAS Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. RAAS Business Overview
Table 94. RAAS Recent Developments
Table 95. Hualan Bio Basic Information
Table 96. Hualan Bio Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 97. Hualan Bio Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Hualan Bio Business Overview
Table 99. Hualan Bio Recent Developments
Table 100. BOHUI Basic Information
Table 101. BOHUI Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 102. BOHUI Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. BOHUI Business Overview
Table 104. BOHUI Recent Developments
Table 105. NUOYI BIO Basic Information
Table 106. NUOYI BIO Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 107. NUOYI BIO Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. NUOYI BIO Business Overview
Table 109. NUOYI BIO Recent Developments
Table 110. SINOPHARM Basic Information
Table 111. SINOPHARM Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 112. SINOPHARM Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. SINOPHARM Business Overview
Table 114. SINOPHARM Recent Developments
Table 115. Guangdong Weilun Basic Information
Table 116. Guangdong Weilun Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 117. Guangdong Weilun Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Guangdong Weilun Business Overview
Table 119. Guangdong Weilun Recent Developments
Table 120. Weiguang Bio Basic Information
Table 121. Weiguang Bio Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 122. Weiguang Bio Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Weiguang Bio Business Overview
Table 124. Weiguang Bio Recent Developments
Table 125. Kangbo Bio Basic Information
Table 126. Kangbo Bio Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 127. Kangbo Bio Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Kangbo Bio Business Overview
Table 129. Kangbo Bio Recent Developments
Table 130. Huarun Boya Basic Information
Table 131. Huarun Boya Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 132. Huarun Boya Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Huarun Boya Business Overview
Table 134. Huarun Boya Recent Developments
Table 135. Taibang Biologic Basic Information
Table 136. Taibang Biologic Prothrombin Complex Concentrate (PCC) Drug Product Overview
Table 137. Taibang Biologic Prothrombin Complex Concentrate (PCC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Taibang Biologic Business Overview
Table 139. Taibang Biologic Recent Developments
Table 140. Global Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Prothrombin Complex Concentrate (PCC) Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Prothrombin Complex Concentrate (PCC) Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Prothrombin Complex Concentrate (PCC) Drug Market Size (M USD), 2025-2035
Figure 5. Global Prothrombin Complex Concentrate (PCC) Drug Market Size (M USD) (2020-2035)
Figure 6. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Prothrombin Complex Concentrate (PCC) Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Prothrombin Complex Concentrate (PCC) Drug Product Life Cycle
Figure 13. Prothrombin Complex Concentrate (PCC) Drug Sales Share by Manufacturers in 2025
Figure 14. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Manufacturers in 2025
Figure 15. Prothrombin Complex Concentrate (PCC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Prothrombin Complex Concentrate (PCC) Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Prothrombin Complex Concentrate (PCC) Drug Revenue in 2025
Figure 18. Industry Chain Map of Prothrombin Complex Concentrate (PCC) Drug
Figure 19. Global Prothrombin Complex Concentrate (PCC) Drug Market PEST Analysis
Figure 20. Global Prothrombin Complex Concentrate (PCC) Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Type
Figure 27. Sales Market Share of Prothrombin Complex Concentrate (PCC) Drug by Type (2020-2025)
Figure 28. Sales Market Share of Prothrombin Complex Concentrate (PCC) Drug by Type in 2025
Figure 29. Market Share of Prothrombin Complex Concentrate (PCC) Drug by Type (2020-2025)
Figure 30. Market Share of Prothrombin Complex Concentrate (PCC) Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Application
Figure 33. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application in 2025
Figure 35. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Application (2020-2025)
Figure 36. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Application in 2025
Figure 37. Global Prothrombin Complex Concentrate (PCC) Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region (2020-2025)
Figure 40. North America Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country in 2024
Figure 43. North America Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country in 2024
Figure 45. U.S. Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Prothrombin Complex Concentrate (PCC) Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Prothrombin Complex Concentrate (PCC) Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Prothrombin Complex Concentrate (PCC) Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Prothrombin Complex Concentrate (PCC) Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country in 2024
Figure 53. Europe Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Prothrombin Complex Concentrate (PCC) Drug Market Size by Country in 2024
Figure 55. Germany Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size by Region in 2024
Figure 68. China Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (K MT)
Figure 79. South America Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country in 2024
Figure 80. South America Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (M USD)
Figure 81. South America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country in 2024
Figure 82. Brazil Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Prothrombin Complex Concentrate (PCC) Drug Production Market Share by Region (2020-2025)
Figure 103. North America Prothrombin Complex Concentrate (PCC) Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Prothrombin Complex Concentrate (PCC) Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Prothrombin Complex Concentrate (PCC) Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Prothrombin Complex Concentrate (PCC) Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Prothrombin Complex Concentrate (PCC) Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Prothrombin Complex Concentrate (PCC) Drug Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Prothrombin Complex Concentrate (PCC) Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Prothrombin Complex Concentrate (PCC) Drug Market Size (M USD), 2025-2035
Figure 5. Global Prothrombin Complex Concentrate (PCC) Drug Market Size (M USD) (2020-2035)
Figure 6. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Prothrombin Complex Concentrate (PCC) Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Prothrombin Complex Concentrate (PCC) Drug Product Life Cycle
Figure 13. Prothrombin Complex Concentrate (PCC) Drug Sales Share by Manufacturers in 2025
Figure 14. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Manufacturers in 2025
Figure 15. Prothrombin Complex Concentrate (PCC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Prothrombin Complex Concentrate (PCC) Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Prothrombin Complex Concentrate (PCC) Drug Revenue in 2025
Figure 18. Industry Chain Map of Prothrombin Complex Concentrate (PCC) Drug
Figure 19. Global Prothrombin Complex Concentrate (PCC) Drug Market PEST Analysis
Figure 20. Global Prothrombin Complex Concentrate (PCC) Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Type
Figure 27. Sales Market Share of Prothrombin Complex Concentrate (PCC) Drug by Type (2020-2025)
Figure 28. Sales Market Share of Prothrombin Complex Concentrate (PCC) Drug by Type in 2025
Figure 29. Market Share of Prothrombin Complex Concentrate (PCC) Drug by Type (2020-2025)
Figure 30. Market Share of Prothrombin Complex Concentrate (PCC) Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Application
Figure 33. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application in 2025
Figure 35. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Application (2020-2025)
Figure 36. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Application in 2025
Figure 37. Global Prothrombin Complex Concentrate (PCC) Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region (2020-2025)
Figure 40. North America Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country in 2024
Figure 43. North America Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country in 2024
Figure 45. U.S. Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Prothrombin Complex Concentrate (PCC) Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Prothrombin Complex Concentrate (PCC) Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Prothrombin Complex Concentrate (PCC) Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Prothrombin Complex Concentrate (PCC) Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country in 2024
Figure 53. Europe Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Prothrombin Complex Concentrate (PCC) Drug Market Size by Country in 2024
Figure 55. Germany Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size by Region in 2024
Figure 68. China Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (K MT)
Figure 79. South America Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country in 2024
Figure 80. South America Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (M USD)
Figure 81. South America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country in 2024
Figure 82. Brazil Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Prothrombin Complex Concentrate (PCC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Prothrombin Complex Concentrate (PCC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Prothrombin Complex Concentrate (PCC) Drug Production Market Share by Region (2020-2025)
Figure 103. North America Prothrombin Complex Concentrate (PCC) Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Prothrombin Complex Concentrate (PCC) Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Prothrombin Complex Concentrate (PCC) Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Prothrombin Complex Concentrate (PCC) Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Prothrombin Complex Concentrate (PCC) Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Prothrombin Complex Concentrate (PCC) Drug Market Share Forecast by Application (2026-2035)
